Company Profile

Falcon Therapeutics Inc
Profile last edited on: 1/18/2018

Personalized neural stem cell therapies to treat glioblastoma
Year Founded
2015
First SBIR Year
2017
Latest SBIR Award
2020
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

60110 Davie
Chapel Hill, NC 27511
   (919) 260-7212
   anna.m.seal@gmail.com
   N/A
Multiple Locations:   
Congressional District:   04
County:   Wake

Public Profile

Falcon Therapeutics Inc is a biotechnology company focused on developing brain cancer treatments. Employing autologous, tumor-homing neural stems cells that destroy cancer cells, the company uses these cells to create personalized genetically engineered neural stem cells to treat the cancer. The company's stem cell therapies represent an entirely new approach to Glioblastoma therapy tusing tumor-homing stem cells technology and create personalized genetically engineered neural stem cells therapies from the skin of cancer patients, enabling them to recover Glioblastoma -- the most common form of primary brain cancer.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2020 2 NIH $1,718,077
Personalized Neural Stem Cell Therapy for Cancer

Key People / Management

  Karen Giroux -- President and Chief Executive Officer

  Matthew Ewend --

  Shawn Hingtgen -- Founder and Director

  Susan Nichols --

  Anna M Seal -- Founder and CFO